Shows
Retina SynthesisEY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMDWe discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.2024-04-0421 min
The Retina Channel PodcastE74- Full-Thickness Macular Holes in Macular Telangiectasia Type 2- Dr. Jong ParkDr. Jong Park discusses surgical mananement of full-thickness macular holes associated with macular telangiectasia. Referenced article: Park JG, Adrean SD, Begaj T, Capone A Jr, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Surgical Management o...2023-12-3032 min
Let’s Talk Retina: an Evolve Medical Education PodcastGA Perspectives: An Unhappy Cataract Patient and a Patient Seeking Cataract ClearanceYasha S. Modi, MD, MHS, and Charles C. Wykoff, MD, PhD, FACS, discuss two cases: a patient who is unhappy with the results of his cataract surgery and a 90-year-old who is seeking cataract clearance. This activity is supported by an independent medical education grant from Apellis Pharmaceuticals.Click here to view Drs. Modi and Wykoff's webinar event, which includes images from the talk. Check out the central hub of this webinar series.Want to register with Evolve Medical Education? Click h...2023-10-0416 minLet’s Talk Retina: an Evolve Medical Education PodcastGA Perspectives: Surgeon With Blind SpotsYasha S. Modi, MD, MHS, and Charles C. Wykoff, MD, PhD, FACS, discuss a case of a surgeon with blind spots in his vision. This activity is supported by an independent medical education grant from Apellis Pharmaceuticals.Click here to view Drs. Modi and Wykoff's webinar event, which includes images from the talk. Check out the central hub of this webinar series.Want to register with Evolve Medical Education? Click here. 2023-10-0414 min
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s ForumImpact of prefilled syringes and masking on post intravitreal injection endophthalmitisOn this episode, Dr. Timothy Murray welcomes Charles C. Wykoff, MD, PhD, FASRS, Retina Consultants of Texas, to discuss the study on the comparison of rates of endophthalmitis (1) following intravitreal injection of antivascular endothelial growth factor therapies with glass-vial preparation (GVP) vs prefilled syringes (PFS) and (2) before and after masking protocols were implemented. Learn if PFS use affected endophthalmitis cases and whether the use of surgical face masks impacts the rate of endophthalmitis.For more information visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the o...2023-09-2817 min
Square Dance Callers, TalkingSquare Dance Callers, Talking with guest Dean Singleton
Dean began his calling career in 1979 at the age of fourteen. During the early 1980s, he started a teen club in Rochester, MN and later was the club caller for the Wykoff Squares. Early in his career, he called in the Minnesota, Iowa, Wisconsin and Arizona area. An owner/producer for Arrowhead Recording, Dean has also recorded on Peak Recordings and Gold Rush. Dean now resides in Arizona. Dean is committed to keeping modern square dancing relevant and growing!! His music is modern with a Rock n' Roll vibe to it!!
2023-08-2545 min
HCPLive PodcastsNew Insight: A Changing Landscape of Retinal Therapeutics with Charles Wykoff, MD, PhDIn this episode, Charles Wykoff, MD, PhD joins Dr. Sheth to provide insight into the recent landmark approval of pegcetacoplan injection (SYFOVRE™) for geographic atrophy, how clinical practice has changed as a result, and both the early struggles with and optimism for an ever-changing treatment landscape.
Please direct any podcast-related inquiries to ciapoce@mjhlifesciences.com. 2023-05-1029 minLet’s Talk Retina: an Evolve Medical Education PodcastEmerging Trends in Geographic Atrophy: Importance of Urgency and Functional Outcomes ImpactWhat biomarkers indicating risk of rapid progression should eye care providers look for in patients with geographic atrophy (GA)? Just how disruptive is GA? And what do real-world patient cases look like? To find out, host Christina Weng, MD, MBA, hears from guest Charles Wykoff, MD, PhD, about the latest data informing assessments of disease progression. Dr. Wykoff also outlines the daily effects of living with GA and shares some real-world patient cases that illustrate how GA progresses when left untreated. This is the final part of a 3-part miniseries adapted from an Evolve M...2023-02-1620 min
New Retina Radio by EyetubeNew Treatment Options and Considerations for AMDAnti-VEGF therapy has been a game changer for patients with AMD; now, the treatment toolbox is getting an overhaul with two new approvals and, hopefully, more on the way. Allen C. Ho, MD, sat down with Robyn Guymer AM, MBBS, PhD, FRANZCO, FAHMS; Charles C. Wykoff, MD, PhD; and Diana V. Do, MD, to discuss how these new treatments are going to change clinical practice and how to educate patients on the pros and cons of each option.2022-05-1936 min
Straight From The Cutter's Mouth: A Retina PodcastEpisode 328: Advancements in Retina, A Multi-Part Interview Series Celebrating Bascom Palmer Eye Institute's 60th AnniversaryBascom Palmer Eye Institute is celebrating its 60th anniversary and multiple guests join to lend historical perspective on major retina advancements at the institute. Dr. Eduardo Alfonso: Introduction (3:00)Dr. John Clarkson: The Founding Five, including discussion of Dr. J. Donald Gass (9:25)Dr. Steve Charles: Development of Modern Vitrectomy Surgical Systems (23:10)Dr. Philip Rosenfeld: Using Avastin for Retinal Disease (28.02)Dr. Mary Lou Lewis: Female Surgeons Entering the Field of Retina (44:57)Drs. Harry W. Flynn Jr. and Richard Forster: Developing Modern Treatments for Endophthalmitis (52:47)Drs. L...2022-01-2100 min
BroadEye: An Ophthalmology PodcastDiabetic Retinopathy: Causes, Risk Factors, Treatment, and The Importance Of Early Diagnosis - Dr. Charles WykoffIn this episode, Surgical and Medical Retina Specialist Dr. Charles Wykoff gives a detailed overview of Diabetic Retinopathy, with a particular focus on the importance of screening and early diagnosis to prevent blindness. Dr. Wykoff further discusses current treatments and therapies, his group's latest research findings, and how technology is changing the landscape for Diabetic Retinopathy and other ophthalmic diseases.
http://broadeye.org/wykoff/
2021-09-1738 minNew Retina Radio by EyetubeAdvances in Gene Therapy for Wet AMDIn this roundtable moderated by Allen C. Ho, MD, experts in gene therapy discuss the latest data, clinical trial hurdles, and the promise these programs hold for patients being treated for wet AMD. Participants include Robert L. Avery, MD; Peter Campochiaro, MD, PhD; Jeffrey S. Heier, MD; Szilárd Kiss, MD; and Charles Wykoff, MD, PhD.This editorially independent podcast is supported with advertising.2021-07-2636 minNew Retina Radio by EyetubeAngiogenesis 2021: Early Phase DataEarly phase data sets are one of the stars of the Angiogenesis, Exudation, and Degeneration annual meeting. Which presentations are worth a second look? John Kitchens, MD, is joined by Nadia Waheed, MD, and Charles Wykoff, MD, PhD, as they share data from their respective presentations showcased at this year’s meeting. After the break, Drs. Kitchens, Waheed, and Wykoff chat what these early phase data could mean for the future of retina care. This editorially independent podcast is supported with advertising.2021-03-2333 minRetina SynthesisDr. Carmen Puliafito Interviews Charles Wykoff MD, PhD: Faricimab Results in DME & nAMDJoin us as Dr. Carmen Puliafito and Charles Wykoff MD, PhD speak about the results. 1 of 3 total parts to "Interpreting Faricimab Phase 3 Data in DME & nAMD"2021-03-0715 minRetina SynthesisDr. Charles Wykoff Interviews Karl Csaky MD, PhD Discussing Faricimab for DME and nAMDJoin us in a discussion with Dr. Charles Wykoff & Karl Csaky MD, PhD on Faricimab for DME and nAMD. Interpreting the Durability Signals from the Phase 3 Programs.2021-03-0714 minRetina SynthesisFocus on Arshad Khanani MD, MA Director of Clinical Services Sierra Eye AssociatesJoin us as Dr. Charles Wykoff dives in a discussion with Arshad Khanani MD, MA in a discussion on Faricimab in the TENAYA and LUCERN Phase 3 nAMD Trials: Interpreting the Results2021-03-0715 minRetina SynthesisFocus on Kourous Rezaei Chief Medical Officer at IVERIC bioFocus on Kourous Rezaei Chief Medical Officer at IVERIC bio in a discussion with Charles Wykoff.2021-03-0609 minRetina SynthesisDr. Philip Rosenfeld Looks at the Future of Macular Degeneration Part 2Dr. Philip Rosenfeld of the Bascom Palmer Eye Institute joins Dr. Charles Wykoff and Dr. Carmen Puliafito furthering questions about geographic atrophy and the future of retina imaging.2021-03-0619 minRetina SynthesisDr. Philip Rosenfeld Looks at the Future of Macular DegenerationDr. Philip Rosenfeld of the Bascom Palmer Eye Institute joins Dr. Charles Wykoff and Dr. Carmen Puliafito in a wide ranging discussion on what every clinician needs to know about macular degeneration.2021-03-0613 minRetina SynthesisFocus on Dr. Jason Ehrlich of Kodiak SciencesJoin Charles C. Wykoff MD, PhD for a conversation with Jason Ehrlich, MD, PhD, Chief Medical Officer, Chief Development Officer at Kodiak Sciences. Jason Ehrlich, ophthalmologist by training discusses insights gleaned along the road of drug development.2021-02-2638 min
ASRS's Retina Health for LifeClinical Trials for Retinal DiseaseClinical trials have ushered in sight-saving advances in the diagnosis, prevention and treatment of retinal disease. On this episode, Dr. Charles Wykoff of Retina Consultants of Texas joins Dr. Timothy Murray to discuss promising clinical trials currently underway for retina conditions and the role patients play in making advances possible. Resources:Learn more about clinical trials and find potential clinical trials for your disease or condition at asrs.org/patients/clinical-trials.2021-01-2035 min
MedEdTalks - OphthalmologyEffective Treatment Interval Extensions in Neovascular Retinal DiseaseThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Charles Wykoff discuss effective treatment interval extensions in neovascular retinal...2020-06-2914 minMedEdTalks - OphthalmologyDrug Delivery Systems in Neovascular Retinal DiseaseThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Charles Wykoff discuss emerging drug delivery systems for the management...2020-06-2915 minStraight From The Cutter's Mouth: A Retina PodcastEpisode 220: Panorama Study 2 year results with Dr. Charles WykoffDr. Charles Wykoff of Retinal Consultants of Houston joins to discuss the recently presented 2 year results of Regeneron's Panorama study of anti-VEGF for moderately severe and severe nonproliferative diabetic retinopathy.2020-03-2200 minStraight From The Cutter's Mouth: A Retina PodcastEpisode 216: Update on Broluciziumab Safety Including HAWK/HARRIER Phase 3 Trial DataDrs. Thomas Albini, Aleksandra Rachitskaya, and Charles Wykoff of the Vit-Buckle Society join for a group discussion of brolucizimab safety data including a discussion of idiopathic ocular inflammation and arterial occlusions from HAWK/HARRIER Phase 3 trials, post-market reports of adverse events, and approach to utilizing brolucizumab going forward.2020-03-0528 min
Dr. Charles C. Wykoff talks eye health on #ConversationsLIVEHost Cyrus Webb welcomes Dr. Charles C. Wykoff, Director of Research at Blanton Eye Institute, stops by #ConversationsLIVE to discuss the importance of our eye health during February which is recognized as Low Vision Awareness Month. He also talks about Wet Age-Related Macular Degeneration and Diabetic Macular Edema, the leading causes iof visual impairment in the U.S.2019-02-1908 min
The Retina Channel PodcastE14-Plasma VEGF Levels after anti-VEGF Injections (DRCR protocol T)- Dr. Charles WykoffDr. Charles Wykoff discusses results of DRCR protocol T ancillary study on plasma free VEGF concentrations after different intravitreal anti-VEGF injections for diabetic macular edema. Full reference of the discussed article: Jampol, L. M., A. R. Glassman, D. Liu, L. P. Aiello, N. M. Bressler, E. J. Duh, S. Quaggin, et al. "Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema." Ophthalmology (Mar 7 2018).2018-05-3020 min
The Retina Channel PodcastE4- 3-year Results of the TREX-AMD Trial- Dr. Charles WykoffDr. Charlie Wykoff describes the treat-and-extend (TREX) approach for the treatment of wet AMD. He then explains the study design and the 3-year results of the TREX-AMD trial. The full reference of the article is: Wykoff, C. C., Ou, W. C., Croft, D. E., Payne, J. F., Brown, D. M., Clark, W. L., . . . Group, T.-A. S. (2017). Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. Br J Ophthalmol. doi:10.1136/bjophthalmol-2017-310822 Please leave your comments in the iTunes show description or email to: theretinachannel@gmail.com2017-12-0829 min